Modern Rheumatology

Article	Citations
Challenges in diagnosing COVID-19 related disease in pediatric patients with rheumatic disease	68
Subjective symptoms contributing to the quality of life of rheumatoid arthritis patients with clinical remission from the IORRA database	32
Correction to: Long-term safety and efficacy of belimumab in Japanese patients with SLE: A 7-year open-label continuation study	28
Dapagliflozin for rheumatic musculoskeletal disease in patients with chronic kidney disease	24
Management of patients with inflammatory rheumatic diseases after treatment failure with a first tumour necrosis factor inhibitor: A narrative review	23
Correction to: Expert perspectives on pathological findings in vasculitis	22
Hydroxychloroquine versus tacrolimus for the treatment of persistently active systemic lupus erythematosus	21
Polypharmacy prevalence and associated factors in patients with systemic lupus erythematosus: A single-centre, cross-sectional study	19
Should we reconsider the definition of elderly-onset rheumatoid arthritis in an ageing society?	18
Japanese version of Patient-Rated Elbow Evaluation is a useful outcome measure that potentially reflects hand function in patients with rheumatoid arthritis who underwent total elbow arthroplasty	18
The impact of the COVID-19 pandemic on SLE	17
Role of rituximab in the treatment of systemic sclerosis: A literature review	16
Safety and effectiveness of denosumab in Japanese patients with rheumatoid arthritis: A 2-year post-marketing surveillance study	16
Long-term efficacy and safety of canakinumab in the treatment of systemic juvenile idiopathic arthritis in Japanese patients: Results from an open-label Phase III study	16
Real-world safety and effectiveness of mepolizumab for patients with eosinophilic granulomatosis with polyangiitis in Japan: A 48-week interim analysis of the MARS study	15
Diagnostic challenge of synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome in pediatric age: A monocentric case series	15
The dietary acid load is associated with disease severity in psoriatic arthritis	14
Clinical investigation for the mechanisms of anaphylactic symptoms in osteoarthritis patients after diclofenac etalhyaluronate administration	14
Extension contracture stiff knee in haemophilia: Surgical timing and procedure for total knee arthroplasty	13
Analysis of the appropriate dose of hydroxychloroquine in systemic lupus erythematosus in Japan	13
IL-18 receptor-α signalling pathway contributes to autoantibody-induced arthritis via neutrophil recruitment and mast cell activation	13
1 mg/day or 10 mg/week? Folic acid supplementation with methotrexate in rheumatoid arthritis	13
Prevalence, patient characteristics and treatment patterns among systemic lupus erythematosus–pulmonary arterial hypertension patients in real-world clinical practice: A retrospective analysis of Medi	13
Efficacy and safety of tocilizumab in Japanese patients with systemic sclerosis and associated interstitial lung disease: A subgroup analysis of a global, randomised, controlled Phase 3 trial	13
Prevalence of systemic lupus erythematosus and age-stratified treatment trends in the Japanese population: a cross-sectional study based on the National Database of Health Insurance Claims	13

Prognostic factors affecting respiratory-related death in patients with rheumatoid arthritis complicated by interstitial lung disease: An ANSWER cohort study	12
Magnetic resonance imaging screening for osteonecrosis of the femoral head after coronavirus disease 2019	12
Two distinct subsets of LDGs (low density granulocytes) in ANCA-associated vasculitis	12
B-Cell depletion therapy in IgG4-related disease: State of the art and future perspectives	12
A multicentre study of clinical features and HLA typing in Japanese patients with ankylosing spondylitis	12
Foot and ankle functions and deformities focus on posterior tibial tendon dysfunction using magnetic resonance imaging in patients with rheumatoid arthritis	12
Antiphospholipid antibody positivity and the thrombotic risk in Japanese patients with anti-neutrophil cytoplasmic antibody-associated vasculitis	12
Risks of femoral localized periosteal thickening in patients with autoimmune inflammatory rheumatic diseases	12
Relation between hydroxychloroquine dose and continuation rate in patients with systemic lupus erythematosus	11
Trends in prevalence, treatment use, and disease burden in patients with eosinophilic granulomatosis with polyangiitis in Japan: Real-world database analysis	11
Response to the comment on ‘Relationships between inflammation markers and the risk of hypertension in primary Sjögren’s syndrome: A retrospective cohort study’	11
Clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of microscopic polyangiitis and granulomatosis	11
High-fat diet-induced obesity accelerates the progression of spontaneous osteoarthritis in senescence-accelerated mouse prone 8	11
Radiographic study of the distal ulna in rheumatoid arthritis with extensor digitorum communis ruptures	11
The long-term safety and tolerability of anifrolumab for patients with systemic lupus erythematosus in Japan: TULIP-LTE subgroup analysis	11
Comparison between the BioPlex 2200 ANA Screen™ and a conventional method with respect to the detection of autoantibodies	11
Thirty-year overview of Japanese autopsy cases of Takayasu arteritis – Results of analysis of Japanese autopsy reports	10
Factors associated with drug retention of mepolizumab in patients with eosinophilic granulomatosis with polyangiitis: A multicentre REVEAL cohort study	10
LncRNA SNHG3 discriminates rheumatoid arthritis from healthy individuals and regulates inflammatory response and oxidative stress via modulating miR-128-3p	10
Factors associated with discrepancies in disease activity as assessed by SDAI and RAPID3 in patients with rheumatoid arthritis: Data from a multicentre observational study (T-FLAG)	10
Association between osteoarthritis-related serum biochemical markers over 10–13 years and knee symptoms in middle-aged adults	9
Safety and efficacy of filgotinib in Japanese patients with rheumatoid arthritis: Week 156 interim results in FINCH 4	9
Characteristics of patients presenting with concomitant carpal tunnel syndrome at the initial diagnosis with rheumatoid arthritis	9
The abundance of regulatory T cell subsets is associated with the clinical outcomes of sarcoidosis	9
Evaluation of articular cartilage degeneration in patients with osteonecrosis of the femoral head using T2 mapping magnetic resonance imaging	9
Pregnancy-related issues from the perspective of patients with inflammatory rheumatic diseases – Results from a survey of the members of the National Association for Inflammatory Rheumatic Diseases	9
Immunological biomarkers in patients with radiographic axial spondyloarthritis, an exploratory longitudinal Swedish study	9
Decreased foot-related quality of life is a risk factor for falls in patients with rheumatoid arthritis	9
Preoperative radiographs underdiagnose the severity of lateral femoral and medial trochlear cartilage damage in varus osteoarthritis knees	9
Comprehensive risk analysis of postoperative complications in patients with rheumatoid arthritis for the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the managemen	8
Rheumatologic manifestations in a cohort of patients with Vogt–Koyanagi–Harada disease	8
Association between patient-reported outcomes and impairments in work and activity in patients with rheumatoid arthritis in clinical remission: A retrospective analysis using the IORRA database	8
The association between difficult-to-treat rheumatoid arthritis and probable sarcopenia	8
Factors related to acceptance of COVID-19 vaccine booster doses among patients with autoimmune and rheumatic diseases in Japan: A single-centre cross-sectional survey	8
Beneficial effects of apremilast on genital ulcers, skin lesions, and arthritis in patients with Behçet’s disease: A systematic review and meta-analysis	8
Management review of scleroderma renal crisis: An update with practical pointers	8
Tacrolimus as an alternative treatment for patients with juvenile idiopathic arthritis	8
MEFV E148Q variant is more associated with familial Mediterranean fever when combined with other non-exon 10 MEFV variants in Japanese patients with recurrent fever	8
Non-drug and surgical treatment algorithm and recommendations for the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis—secondary	8
Integrated safety analysis of filgotinib treatment for rheumatoid arthritis in patients from Japan over a median of 1.5 years	8
A multianalyte assay for the detection of dermatomyositis-related autoantibodies based on immunoprecipitation combined with immunoblotting	7
Clinical and angiographic outcomes of mycophenolate versus methotrexate in South Asian patients of Takayasu arteritis: Results from an open-label, outcome-assessor blinded randomized controlled trial	7
The importance of small joint involvement in oligoarticular juvenile idiopathic arthritis	7
Patients’ perspectives of rheumatoid arthritis treatment: a questionnaire survey for the 2020 update of the Japan college of rheumatology clinical practice guidelines	7
Extraction of characteristic serum microRNAs and prediction of target genes in IgG4-related dacryoadenitis and sialadenitis	7
Have the radiographic characteristics of total knee arthroplasty recipients in rheumatoid arthritis changed after the induction of biologic disease modifying antirheumatic drugs?	7
Intensive treatment for the progression of joint damage in rheumatoid arthritis patients with low disease activity or remission	7
Safety and effectiveness of sarilumab in Japanese patients with rheumatoid arthritis refractory to previous treatments: An interim analysis of a post-marketing surveillance	7
Efficacy and tolerability of subcutaneously administered methotrexate including dose escalation in long-term treatment of rheumatoid arthritis in a Japanese population	7
Real-world safety and efficacy of CT-P13, an infliximab biosimilar, in Japanese rheumatoid arthritis patients naïve to or switched from biologics	7

Checklist for rapid assessment of independence in children with pediatric rheumatic diseases in transition to adult medical care	7
Systematic review for the treatment of older rheumatoid arthritis patients informing the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid	7
The serum immunoglobulin G titres against Porphyromonas gingivalis as a predictor of clinical response to 1-year treatment with biological disease-modifying antirheumatic drugs in rheumatoid ar	7
Phenotypic landscape of systemic lupus erythematosus: An analysis of the Kyoto Lupus Cohort	7
Changes in treatment adherence and behaviour during the COVID-19 pandemic in Japanese patients with rheumatoid arthritis: Results from cross-sectional study in the IORRA cohort	7
Region specificity of rheumatoid foot symptoms associated with ultrasound-detected synovitis and joint destruction	7
Gene regulatory network study of rheumatoid arthritis in single-cell chromatin landscapes of peripheral blood mononuclear cells	7
Nation-wide cohort study of remission induction therapy using rituximab in Japanese patients with antineutrophil cytoplasmic antibody–associated vasculitis: Effectiveness and safety in the first 6 mon	7
Perspectives on current and emerging therapies for immunoglobulin G4–related disease	6
Enthesitis in patients with Behçet’s disease: A single-centre retrospective cohort study in Japan	6
Safety and effectiveness of certolizumab pegol in Japanese patients with rheumatoid arthritis: Results from a 24-week post-marketing surveillance study	6
COVID-19 in familial Mediterranean fever: Clinical course and complications related to primary disease	6
Gender differences in patient experience in idiopathic inflammatory myopathies: Subanalysis from the COVAD dataset	6
Clinical features of Behçet’s disease patients with joint symptoms in Japan: A national multicenter study	6
Urticaria and increased risk of rheumatoid arthritis: a two-sample Mendelian randomisation study in European population	6
Interluekin-6 inhibitors for the treatment of adult-onset Still’s disease	6
Association of spinal ankylosis with spinal mobility and functional impairment in radiographic axial spondyloarthritis: A computed tomography study	6
Impact of pain in other body regions on the foot-specific quality of life in patients with hallux valgus	6
Clinical observations of osteoporosis in Japanese patients with rheumatoid arthritis	6
Lupus manifestations in children with primary immunodeficiency diseases: Comprehensive phenotypic and genetic features and outcome	6
Differences in sex- and age-associated mortality in patients with anti-MDA5-positive dermatomyositis	6
C-reactive protein and ground-glass opacity as predictors for intractable interstitial lung disease in patients with systemic sclerosis under cyclophosphamide treatment regardless of concomitant gluco	6
Diagnostic utility of serum biomarkers in large vessel vasculitis and their correlation with positron emission tomography	6
MRI-based predictors of spinal ankylosis progression: ESSR framework for axial spondyloarthritis	6
The real-world effectiveness of anti-RANKL antibody denosumab on the clinical fracture prevention in patients with rheumatoid arthritis: The ANSWER cohort study	6
Trend in prescription and treatment retention of molecular-targeted drugs in 121,131 Japanese patients with rheumatoid arthritis: A population-based real-world study	6
Systematic literature review and meta-analysis of the epidemiology and clinical burden of eosinophilic granulomatosis with polyangiitis	6
Mid-term Outcomes of Distal Tibial Oblique Osteotomy for Rheumatoid Arthritis-Associated Ankle Arthropathy: A Comparison with Osteoarthritis Outcomes	6
A single-centre retrospective study of factors affecting steroid-free remission of immunoglobulin G4–related disease conducted in South Korea: A notable outcome after complete resection	6
Estimated excretion and clearance of uric acid as optimal surrogate indices for daily urinary uric acid excretion	6
Therapeutic effect of targeting Substance P on the progression of osteoarthritis	6
Expert perspectives on pathological findings in vasculitis	6
Biases in large-vessel vasculitis	6
Clinical features and risk factors for Baker’s cyst in patients with rheumatoid arthritis	6
Disease severity and genotype–phenotype correlation in adult patients with familial Mediterranean fever	6
A multicentre, large-scale, observational study of tocilizumab in patients with giant cell arteritis in Japan	5
Factors associated with frailty in rheumatoid arthritis patients with decreased renal function	5
Dipeptidyl peptidase-4 inhibitor use is associated with a lower erythrocyte sedimentation rate in patients with remitting seronegative symmetrical synovitis with pitting oedema and pre-existing diabet	5
Iguratimod versus salazosulfapyridine in rheumatoid arthritis patients with an inadequate response to methotrexate: Adjusted with propensity score matching	5
Frequency–response relationship between exercise and locomotive syndrome across age groups: Secondary analysis of a nationwide cross-sectional study in Japan	5
A nationwide questionnaire survey on the prevalence of ankylosing spondylitis and non-radiographic axial spondyloarthritis in Japan	5
The effect of intra-articular steroid injection on the cartilage and tendon thicknesses in juvenile idiopathic arthritis	5
Association between poor sleep quality and locomotive syndrome in middle-aged and older women: A community-based, cross-sectional study	5
Safety of baricitinib in Japanese patients with rheumatoid arthritis in clinical use: 3-year data of all-case postmarketing surveillance study	5
Prevalence of social frailty in patients with rheumatoid arthritis: Data from a multicentre observational study (T-FLAG study)	5
Clinical significance of HScore and MS score comparison in the prognostic evaluation of anti-MDA5-positive patients with dermatomyositis and interstitial lung disease	5
Correction to: Risk of hospitalized infections in older elderly patients with rheumatoid arthritis treated with tocilizumab or other biological/targeted synthetic disease-modifying antirheumatic drugs	5
Risk factors for serious infections and infection-related mortality in patients with microscopic polyangiitis: Multicentre REVEAL cohort study	5
Heart function in juvenile idiopathic arthritis patients: A biventricular two-dimensional speckle-tracking echocardiography study	5
Discrepancy between SAA and CRP levels linked to the difference of SAA/CRP ratio in the patients with early rheumatoid arthritis	5
Illustrations of rheumatoid arthritis symptoms to promote communication between patients and physicians	5
Age and symptoms at onset of ankylosing spondylitis in Japanese patients	5
Safety and efficacy of switching immunosuppressive drugs for maintenance treatment in patients with systemic lupus erythematosus: A retrospective cohort study	5
The implication of long non-coding RNA expression profile in rheumatoid arthritis: Correlation with treatment response to tumor necrosis factor inhibitor	5
Is histopathological synovitis score a predictor of postoperative requirement for additional or alternative drug treatment in the patients with rheumatoid arthritis?	5
Assessing the efficacy of haemoperfusion for dermatomyositis-associated acute exacerbation of interstitial lung disease: A multicentre retrospective study	5
Mast cells can produce transforming growth factor β1 and promote tissue fibrosis during the development of Sjögren’s syndrome-related sialadenitis	5
Efficacy and safety of sarilumab in patients with rheumatoid arthritis stratified by age (<65 and ≥65 years): A post hoc analysis of Japanese Phase 3 clinical trials	5
Efficacy of local oxygen–ozone therapy for the treatment of digital ulcer refractory to medical therapy in systemic sclerosis: A randomized controlled study	5
Assessing the diagnostic and therapeutic value of submandibular gland elastography in patients with immunoglobulin G4-related sialadenitis	5
Rheumatoid arthritis relapse in patients with other iatrogenic immunodeficiency-associated lymphoproliferative disorders and its treatment	5
Test-retest reliability and validity of the 6 minute stepper test to evaluate functional exercise capacity in patients with ankylosing spondylitis	5
Intervertebral fusion sites in patients with ankylosing spondylitis: A computed tomography study	5
Distinct impact of RF and ACPA titer on the effectiveness and persistency of biologics and JAK inhibitors: The ANSWER cohort study	5
Evaluation of medication withdrawal in patients with non-systemic juvenile idiopathic arthritis in Japan using a web-based survey	5
Clinical features of polymyalgia rheumatica patients in Japan: Analysis of real-world data from 2015 to 2020	5
Cut-off values for achieving osteoporosis treatment goals in women with rheumatoid arthritis receiving denosumab	5
Clinical features of large vessel vasculitis (LVV): Elderly-onset versus young-onset	5
Nation-wide survey of the treatment trend of microscopic polyangiitis and granulomatosis with polyangiitis in Japan using the Japanese Ministry of Health, Labour and Welfare Database	5
Risk factors for cytomegalovirus reactivation during the treatment of ANCA-associated vasculitis: A retrospective cohort study of the J-CANVAS study	4
Efficacy of anifrolumab in systemic lupus erythematosus patients with serological manifestations: A post hoc analysis of the Japan subgroup of the TULIP-2 trial	4
Periprosthetic fragility fracture of the femur after primary cementless total hip arthroplasty	4
High serum IgA levels in patients with IgG4-related disease are associated with mild inflammation, sufficient disease-specific features, and favourable responses to treatments	4
Benefits and risks of haematopoietic stem cell transplantation for systemic sclerosis: A systematic review and meta-analysis	4
Risk factor analysis of vertebral fractures requiring surgery in patients with ankylosing spondylitis	4
Post hoc analysis of patients with rheumatoid arthritis under clinical remission in two Japanese Phase 3 trials of peficitinib treatment (RAJ3 and RAJ4)	4
The effects of sarilumab as monotherapy and in combination with non-methotrexate disease-modifying anti-rheumatic drugs on unacceptable pain in patients with rheumatoid arthritis: A post-hoc analysis	4
Rheumatoid factor value for determining the first biologic agent to use for non-systemic juvenile idiopathic arthritis	4
Concordance between practice and published evidence in the management of ANCA-associated vasculitis in Japan: A cross-sectional web-questionnaire survey	4
Clues to mortality trends and their related factors in IgG4-related disease: A Japanese single-centre retrospective study	4

Frequent detection of antinuclear antibodies and low-titre rheumatoid factor in female patients with undifferentiated peripheral spondyloarthritis in Japan: A prospective observational study	4
Influence of concomitant methotrexate use on the clinical effectiveness, retention, and safety of abatacept in biologic-naïve patients with rheumatoid arthritis:Post-hocsubgroup analysis of the	4
Increased risk of malignancy in HLA-B27-positive patients with ankylosing spondylitis requiring biologics for sustained inflammation: A long-term, single-center retrospective study	4
Systematic review and meta-analysis of biosimilar for the treatment of rheumatoid arthritis informing the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the manageme	4
Frozen shoulder. An overview of pathology and biology with hopes to novel drug therapies	4
Age-related differences in the clinical phenotypes of Behçet’s disease: The experience of two referral centres	4
Treatment strategies for elderly-onset rheumatoid arthritis in the new era	4
Assessment of quality of life, school performance, and physical activity in adolescents with Familial Mediterranean fever	4
Risk factors that hinder locomotive syndrome improvement following surgery for musculoskeletal diseases in older patients: A multicentre prospective study	4
Comparative analysis of low-field magnetic resonance imaging in patients with rheumatoid arthritis treated with certolizumab pegol or infliximab	4
Comparison of safety and effectiveness between etanercept biosimilar LBEC0101 and reference in patients with rheumatoid arthritis in real-world data using the KURAMA cohort	4
Predictors of infliximab refractory intestinal Behçet’s syndrome: A retrospective cohort study from the Shanghai Behçet’s syndrome database	4
Nationwide epidemiological survey of juvenile idiopathic arthritis during transition to young adulthood in Japan using the National Database of Designated Incurable Diseases of Japan	4
Blood monocyte fraction and computed tomography attenuation value of bone marrow in fever of unknown origin: A retrospective analysis for differentiating adult-onset Still’s disease and intravascular	4
Patient characteristics, diagnostic testing, and initial treatment profiles of patients with connective tissue disease-associated pulmonary arterial hypertension using a Japanese claims database	4
Early full weight-bearing and gait exercise after cemented total ankle arthroplasty with a modified anterolateral approach	4
Global research trends in hyperuricemia: a bibliometric and visualized study	4
The bioimpedance phase angle may be associated with frailty in rheumatoid arthritis patients: Results from a prospective, cohort study	4
Anti-ganglionic nicotinic acetylcholine receptor α3 subunit antibody as a potential biomarker associated with lupus enteritis	4
Hyperglobulinemia predicts increased risk of mortality in primary Sjögren’s syndrome: Based on a Chinese multicentre registry	4
Chemoprophylaxis against Pneumocystis jirovecii pneumonia in Japanese patients with ANCA-associated vasculitis: An observational study	4
Impact of concomitant chronic kidney disease on hospitalised infections and remission in patients with rheumatoid arthritis: results from the IORRA cohort	4
Clinical study on the utility of allergy tests to detect IgE-mediated anaphylaxis after diclofenac etalhyaluronate administration	4
Challenges faced by nurses engaged in rheumatology care in Japan	4
Factors contributing to the improvement in Japanese Health Assessment Questionnaire after 3 years of treatment with abatacept in biologic-naïve rheumatoid arthritis patients: Interim results of a long	4